These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15111534)

  • 1. Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases.
    Wilson SR; Vakili BA; Sherman W; Sanborn TA; Brown DL
    Diabetes Care; 2004 May; 27(5):1137-42. PubMed ID: 15111534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
    Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
    Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy.
    Berger JS; Slater JN; Sherman W; Green SJ; Sanborn TA; Brown DL
    J Thromb Thrombolysis; 2005 Feb; 19(1):47-54. PubMed ID: 15976967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years.
    Marso SP; Giorgi LV; Johnson WL; Huber KC; Laster SB; Shelton CJ; McCallister BD; Coen MM; Rutherford BD
    Am Heart J; 2003 Feb; 145(2):270-7. PubMed ID: 12595844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.
    Berger JS; Sanborn TA; Sherman W; Brown DL
    Am Heart J; 2006 May; 151(5):1026-31. PubMed ID: 16644329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
    Brogan GX; Peterson ED; Mulgund J; Bhatt DL; Ohman EM; Gibler WB; Pollack CV; Farkouh ME; Roe MT
    Diabetes Care; 2006 Jan; 29(1):9-14. PubMed ID: 16373888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry.
    Schnell O; Schäfer O; Kleybrink S; Doering W; Standl E; Otter W;
    Diabetes Care; 2004 Feb; 27(2):455-60. PubMed ID: 14747228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.
    Kim LK; Wong SC; Minutello RM; Bergman G; Feldman DN
    J Invasive Cardiol; 2010 Mar; 22(3):94-100. PubMed ID: 20197573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.
    Nikolsky E; Mehran R; Turcot D; Aymong ED; Mintz GS; Lasic Z; Lansky AJ; Tsounias E; Moses JW; Stone GW; Leon MB; Dangas GD
    Am J Cardiol; 2004 Aug; 94(3):300-5. PubMed ID: 15276092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
    Nikolsky E; Holmes DR; Mehran R; Dangas G; Schampaert E; Morice MC; Schofer J; Sousa JE; Fahy M; Na Y; Donohoe DJ; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):896-906. PubMed ID: 18498145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
    Feldman DN; Wong SC; Bergman G; Minutello RM
    J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty.
    Van Belle E; Ketelers R; Bauters C; Périé M; Abolmaali K; Richard F; Lablanche JM; McFadden EP; Bertrand ME
    Circulation; 2001 Mar; 103(9):1218-24. PubMed ID: 11238264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center registry).
    Halon DA; Merdler A; Flugelman MY; Rennert HS; Weisz G; Shahla J; Lewis BS
    Am J Cardiol; 2000 Jun; 85(12):1420-6. PubMed ID: 10856386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
    Gumina RJ; Yang EH; Sandhu GS; Prasad A; Bresnahan JF; Lennon RJ; Rihal CS; Holmes DR; Singh M
    Mayo Clin Proc; 2008 Sep; 83(9):995-1001. PubMed ID: 18775199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and coronary revascularization.
    Flaherty JD; Davidson CJ
    JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.